Drug Approval | July 02, 2024
Lynparza and Imfinzi combination recommended for approval in the EU by CHMP for recurrent endometrial cancer
Imfinzi also recommended for patients with mismatch repair deficient disease
Imfinzi also recommended for patients with mismatch repair deficient disease
This initiative underscores a steadfast commitment of ONGC to sustainable development and enhanced public health services
Aster CMI Hospital has successfully implemented several key digital health initiatives contributing to this accreditation
GL0034 administered once-weekly confirmed clinically meaningful weight loss and improved glucometabolic parameters over a 4-week treatment period in individuals with obesity
The consultative meet, a first of its kind, will bring together representatives from diverse domains of Traditional Medicine (TM) in India
India's healthcare sector anticipates telemedicine reaching US$ 5.4 billion by 2025, with AI growing at 45% by 2024 and Healthtech jobs increasing 15-20%
Fischer MVL envisages to offer a diverse portfolio of diagnostic solutions
Accelerating sustainability in Indian pharma industry
DurA Cycle is designed for large-scale commercial manufacturing of monoclonal antibodies,
Canagliflozin and Metformin Hydrochloride Tablets are used to treat type 2 diabetes mellitus
Subscribe To Our Newsletter & Stay Updated
